RECURSION PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Taylor Ben R | Chief Financial Officer | Sale | 21,383 | $4.18 | $89,381 | 761,550 | Dec 29, 2025 |
| Khan Najat | Chief R&D Commercial Officer | Sale | 124,403 | $4.41 | $548,617 | 611,135 | Dec 22, 2025 |
| Gibson Christopher | Chief Executive Officer | C | 40,000 | — | — | 953,839 | Dec 19, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 7,057 | $4.33 | $30,557 | 782,933 | Dec 15, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 40,000 | $4.63 | $185,200 | 933,839 | Dec 4, 2025 |
| Borgeson Blake | — | Sale | 220,000 | $4.37 | $961,400 | 6,869,863 | Dec 2, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 2,271 | $4.03 | $9,152 | 789,990 | Nov 25, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 11,908 | $4.14 | $49,299 | 792,261 | Nov 17, 2025 |
| Khan Najat | Chief R&D Commercial Officer | Tax Withholding | 17,584 | $4.14 | $72,798 | 735,538 | Nov 17, 2025 |
| Gibson Christopher | Chief Executive Officer | C | 40,000 | — | — | 953,839 | Nov 17, 2025 |
| Khan Najat | Chief R&D Commercial Officer | Award / Grant | 84,925 | — | — | 753,122 | Nov 5, 2025 |
| Gibson Christopher | Chief Executive Officer | Gift | 20,000 | — | — | 954,229 | Nov 4, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 100,000 | $5.70 | $570,000 | 954,229 | Oct 23, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 100,000 | $6.04 | $604,000 | 974,229 | Oct 10, 2025 |
| Li Dean Y | — | Award / Grant | 1,961 | — | — | 1,238,528 | Oct 1, 2025 |
| Dar Zavain | — | Award / Grant | 2,941 | — | — | 138,758 | Oct 1, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 100,000 | $4.76 | $476,000 | 954,229 | Sep 25, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 7,057 | $4.83 | $34,085 | 804,169 | Sep 15, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 100,000 | $4.71 | $471,000 | 974,229 | Sep 10, 2025 |
| Gibson Christopher | Chief Executive Officer | C | 100,000 | — | — | 1,054,229 | Aug 26, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 11,908 | $5.64 | $67,161 | 811,226 | Aug 15, 2025 |
| Gibson Christopher | Chief Executive Officer | Tax Withholding | 40,390 | $5.64 | $227,800 | 954,229 | Aug 15, 2025 |
| Khan Najat | Chief R&D Commercial Officer | Sale | 36,599 | $5.52 | $202,026 | 668,197 | Aug 15, 2025 |
| Gibson Christopher | Chief Executive Officer | C | 17,875 | — | — | 17,875 | Aug 11, 2025 |
| Li Dean Y | — | Award / Grant | 1,949 | — | — | 1,236,567 | Jul 1, 2025 |
| Dar Zavain | — | Award / Grant | 2,924 | — | — | 135,817 | Jul 1, 2025 |
| Sun Elaine D | — | Award / Grant | 11,008 | — | — | 47,557 | Jun 18, 2025 |
| Borgeson Blake | — | Award / Grant | 22,016 | — | — | 7,089,863 | Jun 18, 2025 |
| Michor Franziska | — | Award / Grant | 22,016 | — | — | 127,053 | Jun 18, 2025 |
| HERSHBERG ROBERT | — | Award / Grant | 22,016 | — | — | 73,732 | Jun 18, 2025 |
| Dar Zavain | — | Award / Grant | 22,016 | — | — | 132,893 | Jun 18, 2025 |
| Bumpus Namandje | — | Award / Grant | 11,008 | — | — | 47,557 | Jun 18, 2025 |
| Li Dean Y | — | Award / Grant | 22,016 | — | — | 1,234,618 | Jun 18, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 7,057 | $4.92 | $34,720 | 823,134 | Jun 16, 2025 |
| Khan Najat | Chief R&D Commercial Officer | Tax Withholding | 3,796 | $4.25 | $16,133 | 708,585 | May 15, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 11,908 | $4.25 | $50,609 | 830,191 | May 15, 2025 |
| Gibson Christopher | Chief Executive Officer | Tax Withholding | 36,197 | $4.25 | $153,837 | 1,081,253 | May 15, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 26,571 | $5.10 | $135,512 | 842,099 | Apr 1, 2025 |
| Li Dean Y | — | Award / Grant | 2,268 | — | — | 79,618 | Apr 1, 2025 |
| Dar Zavain | — | Award / Grant | 2,745 | — | — | 110,877 | Apr 1, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 138,574 | $6.04 | $836,987 | 1,117,450 | Mar 27, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 7,057 | $6.84 | $48,270 | 868,670 | Mar 17, 2025 |
| Bumpus Namandje | — | Award / Grant | 36,549 | — | — | 36,549 | Mar 17, 2025 |
| Sun Elaine D | — | Award / Grant | 36,549 | — | — | 36,549 | Mar 17, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 20,000 | $6.58 | $131,600 | 1,256,024 | Mar 6, 2025 |
| Gibson Christopher | Chief Executive Officer | Tax Withholding | 17,132 | $10.64 | $182,284 | 1,256,024 | Feb 18, 2025 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 10,879 | $10.64 | $115,753 | 875,727 | Feb 18, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 20,000 | $7.68 | $153,600 | 1,273,156 | Feb 5, 2025 |
| Taylor Ben R | Chief Financial Officer | Award / Grant | 35,018 | — | — | 879,228 | Feb 3, 2025 |
| Khan Najat | Chief R&D Commercial Officer | Award / Grant | 8,049 | — | — | 715,134 | Feb 3, 2025 |